Biomaterials Market Strategic Trends ,Growth, Revenue, Demand & Forecast Till 2025| Grand View Research, Inc
“The global biomaterials market size was valued at USD 83.9 billion in 2017 and is likely to register a CAGR of 14.7% over the forecast period.�
The global biomaterial market size is expected to reach USD 250.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 14.7% during the forecast period. Technological innovations in the field of biomaterials are leading to development of advanced products, which in turn is working in favor of the market. Widening base of geriatric population worldwide and subsequent rise in prevalence of cardiovascular and orthopedic disorders are providing a fillip to the market. Biomaterials are now widely used in healthcare fields such as cardiovascular, orthopedic, dental, plastic medical procedure, wound repair, ophthalmology and neurological conditions. Furthermore, they are utilized in different advanced healthcare technologies such as cosmetic surgeries, tissue engineering, medical implants, and advanced drug delivery. Geographically, North America held the largest share in the biomaterials market in 2017. The growth of the regional market can be attributed to various technological and mechanical progressions, high utility of medical services, growing geriatric population, and higher medical insurance coverage. Some of the prominent companies operating in the market are DSM; BASF SE; Evonik Industries AG.; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/biomaterials-industry
Follow Us:
Further key findings from the report suggest: Rapid advancements in the field of genetics and increasing usage of biomaterials in oncology, personal genomics, and agrigenomics are expected to drive the market
Factors such as high cost of instruments and platforms, ethical concerns, and ambiguous reimbursement policies in some countries are estimated to negatively impact the growth of the market
Based on products, the natural segment is anticipated to register the highest CAGR of close to 16.7% during the forecast period
On the basis of application, orthopedics was the most prominent segment in 2017, accounting for more than 20.0% of the market revenue
There are many industrial scale healthcare projects and genome research projects launched in North American & European countries for improving the adoption of advanced healthcare technologies
Strong presence of a raft of biomaterial technology providers, better infrastructure, patient awareness, and good healthcare facilities in these regions are aiding market growth.
Grand View Research has segmented the global biomaterials market based on products, application, technique, end use, and region: Biomaterials Products Outlook (Revenue, USD Million, 2014 - 2025) Metallic
Natural
Ceramics
Polymers
Biomaterials Application Outlook (Revenue, USD Million, 2014 - 2025) Cardiovascular
o
Sensors
o
Stents
o
Guidewires
o
Implantable Cardiac Defibrillators
o
Pacemakers
o
Vascular Grafts
o
Others
Ophthalmology
Follow Us:
o
Synthetic Corneas
o
Intraocular Lens
o
Contact Lens
o
Ocular Tissue Replacement
o
Others
Dental o
Tissue Regeneration Materials
o
Dental Implants
o
Bone Grafts & Substitutes
o
Dental Membranes
o
Others
Orthopedic o
Joint Replacement biomaterials
o
Orthobiologics
o
Bioresorbable Tissue Fixation Products
o
Viscosupplementation
o
Spine Biomaterial
o
Others
Wound Healing o
Fracture Healing Device
o
Adhesion Barrier
o
Skin Substitutes
o
Internal Tissue Sealant
o
Surgical Hemostats
o
Others
Tissue Engineering
Plastic Surgery
Follow Us:
o
Facial Wrinkle Treatment
o
Soft Tissue Fillers
o
Craniofacial Surgery
o
Bioengineered Skins
o
Peripheral Nerve Repair
o
Acellular Dermal Matrices
o
Others
Neurology o
Neural Stem Cell Encapsulation
o
Shunting Systems
o
Hydrogel Scaffold For CNS Repair
o
Cortical Neural Prosthetics
o
Others
Others
Biomaterials Regional Outlook (Revenue, USD Million, 2014 - 2025) North America
o
U.S.
o
Canada
Europe o
Germany
o
U.K.
Asia Pacific o
Japan
o
China
Latin America o
Brazil
o
Mexico
Middle East Africa o
South Africa
Browse Related Category Reports @ www.grandviewresearch.com/industry/biotechnology Table of Content of Biomaterials Market Chapter 1 Research Methodology & Scope 1.1 Information Procurement 1.2 Information or Data Analysis 1.3 Market Formulation & Validation Chapter 2 Executive Summary
Follow Us:
Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.1.1 Market Driver Analysis 3.1.1.1 Increasing prevalence of diseases with increasing healthcare expenditures 3.1.1.2 Emerging advances in biomaterials technologies 3.1.1.3 Emerging applications in broad range of areas 3.1.2 Market Restraint Analysis 3.1.2.1 Improper reimbursement facilities and lack of tissue availability 3.1.2.2 Problems related to the biocompatibility of biomaterials 3.2 Next Generation Sequencing - SWOT Analysis, By Factor (Political & Legal, Economic And Technological) 3.3 Industry Analysis - Porter’s Chapter 4 Market Categorization: Product Estimates & Trend Analysis 4.1 Biomaterials Market: Product Movement Analysis 4.2 Metallic 4.2.1 Metallic biomaterials market, 2014 - 2025 (USD Billion) 4.3 Natural 4.3.1 Natural biomaterials market, 2014 - 2025 (USD Billion) 4.4 Ceramics 4.4.1 Ceramics biomaterials market, 2014 - 2025 (USD Billion) 4.5 Polymers 4.5.1 Polymers biomaterials market, 2014 - 2025 (USD Billion) Chapter 5 Market Categorization: Applications & Trend Analysis 5.1 Biomaterials Market: Application Movement Analysis 5.2 Cardiovascular 5.2.1 Cardiovascular market, 2014 - 2025 (USD Billion) 5.2.2 Sensors 5.2.2.1 Sensors market, 2014 - 2025 (USD Billion) 5.2.3 Stents 5.2.3.1 Stents market, 2014 - 2025 (USD Billion) 5.2.4 Guidewires 5.2.4.1 Guidewires market, 2014 - 2025 (USD Billion) 5.2.5 Implantable cardiac defibrillators
Follow Us:
5.2.5.1 Implantable cardiac defibrillators market, 2014 - 2025 (USD Billion) 5.2.6 Pacemakers 5.2.6.1 Pacemakers market, 2014 - 2025 (USD Billion) 5.2.7 Vascular grafts 5.2.7.1 Vascular grafts market, 2014 - 2025 (USD Billion) 5.2.8 Others 5.2.8.1 Others market, 2014 - 2025 (USD Billion) 5.3 Ophthalmology 5.3.1 Ophthalmology market, 2014 - 2025 (USD Billion) 5.3.2 Synthetic corneas 5.3.2.1 Synthetic corneas market, 2014 - 2025 (USD Billion) 5.3.3 Intraocular lens 5.3.3.1 Intraocular lens market, 2014 - 2025 (USD Billion) 5.3.4 Contact lens 5.3.4.1 Contact lens market, 2014 - 2025 (USD Billion) 5.3.5 Ocular tissue replacement 5.3.5.1 Ocular tissue replacement market, 2014 - 2025 (USD Billion) 5.3.6 Others 5.3.6.1 Others market, 2014 - 2025 (USD Billion) 5.4 Dental 5.4.1 Dental market, 2014 - 2025 (USD Billion) 5.4.2 Tissue regeneration materials 5.4.2.1 Tissue regeneration materials market, 2014 - 2025 (USD Billion) 5.4.3 Dental implants 5.4.3.1 Dental implants market, 2014 - 2025 (USD Billion) 5.4.4 Bone grafts & substitutes 5.4.4.1 Bone grafts and substitutes market, 2014 - 2025 (USD Billion) 5.4.5 Dental membranes 5.4.5.1 Dental membranes market, 2014 - 2025 (USD Billion) 5.4.6 Others 5.4.6.1 Others market, 2014 - 2025 (USD Billion) 5.5 Orthopedic
Follow Us:
5.5.1 Orthopedic market, 2014 - 2025 (USD Billion) 5.5.2 Joint replacement biomaterials 5.5.2.1 Joint replacement biomaterials market, 2014 - 2025 (USD Billion) 5.5.3 Orthobiologics 5.5.3.1 Orthobiologics market, 2014 - 2025 (USD Billion) 5.5.4 Bio-resorbable tissue fixation products 5.5.4.1 Bio-resorbable tissue fixation products market, 2014 - 2025 (USD Billion) 5.5.5 Viscosupplementation 5.5.5.1 Viscosupplementation market, 2014 - 2025 (USD Billion) 5.5.6 Spine biomaterials 5.5.6.1 Spine biomaterials market, 2014 - 2025 (USD Billion) 5.5.7 Others 5.5.7.1 others market, 2014 - 2025 (USD Billion) 5.6 Wound Healing 5.6.1 Wound healing market, 2014 - 2025 (USD Billion) 5.6.2 Fracture healing device 5.6.2.1 Fracture healing device market, 2014 - 2025 (USD Billion) 5.6.3 Adhesion barrier 5.6.3.1 Adhesion barrier market, 2014 - 2025 (USD Billion) 5.6.4 Skin substitutes 5.6.4.1 Skin substitutes market, 2014 - 2025 (USD Billion) 5.6.5 Internal tissue sealant 5.6.5.1 Internal tissue sealant market, 2014 - 2025 (USD Billion) 5.6.6 Surgical hemostats 5.6.6.1 Surgical hemostats market, 2014 - 2025 (USD Billion) 5.6.7 Others 5.6.7.1 others market, 2014 - 2025 (USD Billion) 5.7 Tissue Engineering 5.7.1 Tissue engineering market, 2014 - 2025 (USD Billion) 5.8 Plastic Surgery 5.8.1 Plastic surgery market, 2014 - 2025 (USD Billion) 5.8.2 Facial wrinkle treatment
Follow Us:
5.8.2.1 Facial wrinkle treatment market, 2014 - 2025 (USD Billion) 5.8.3 Soft tissue fillers 5.8.3.1 Soft tissue fillers market, 2014 - 2025 (USD Billion) 5.8.4 Craniofacial surgery 5.8.4.1 Craniofacial surgery market, 2014 - 2025 (USD Billion) 5.8.5 Bioengineered skins 5.8.5.1 Bioengineered skins market, 2014 - 2025 (USD Billion) 5.8.6 Peripheral nerve repair 5.8.6.1 Peripheral nerve repair market, 2014 - 2025 (USD Billion) 5.8.7 Acellular dermal matrices 5.8.7.1 Acellular dermal matrices market, 2014 - 2025 (USD Billion) 5.8.8 Others 5.8.8.1 others market, 2014 - 2025 (USD Billion) 5.9 Neurology 5.9.1 Neurology market, 2014 - 2025 (USD Billion) 5.9.2 Neural stem cell encapsulation 5.9.2.1 Neural stem cell encapsulation market, 2014 - 2025 (USD Billion) 5.9.3 Shunting systems 5.9.3.1 Shunting systems market, 2014 - 2025 (USD Billion) 5.9.4 Hydrogel scaffold 5.9.4.1 Hydrogel scaffold market, 2014 - 2025 (USD Billion) 5.9.5 Cortical neural prosthetics 5.9.5.1 Cortical neural prosthetics market, 2014 - 2025 (USD Billion) 5.9.6 Others 5.9.6.1 others market, 2014 - 2025 (USD Billion) Chapter 6 Market Categorization: Regional Estimates & Trend Analysis 6.1 Biomaterials Market Share by Regions and Countries 2017 & 2025 6.2 North America 6.2.1 North America biomaterials market, 2014 - 2025 (USD Billion) 6.2.2 U.S. 6.2.2.1 U.S. biomaterials market, 2014 - 2025 (USD Billion) 6.2.3 Canada
Follow Us:
6.2.3.1 Canada biomaterials market, 2014 - 2025 (USD Billion) 6.3 Europe 6.3.1 Europe biomaterials market, 2014 - 2025 (USD Billion) 6.3.2 Germany 6.3.2.1 Germany biomaterials market, 2014 - 2025 (USD Billion) 6.3.3 U.K. 6.3.3.1 U.K. biomaterials market, 2014 - 2025 (USD Billion) 6.4 Asia Pacific 6.4.1 Asia Pacific biomaterials market, 2014 - 2025 (USD Billion) 6.4.2 Japan 6.4.2.1 Japan biomaterials market, 2014 - 2025 (USD Billion) 6.4.3 China 6.4.3.1 China biomaterials market, 2014 - 2025 (USD Billion) 6.5 Latin America 6.5.1 Latin America biomaterials market, 2014 - 2025 (USD Billion) 6.5.2 Brazil 6.5.2.1 Brazil biomaterials market, 2014 - 2025 (USD Billion) 6.5.3 Mexico 6.5.3.1 Mexico biomaterials market, 2014 - 2025 (USD Billion) 6.6 Middle East Africa 6.6.1 Middle East Africa biomaterials market, 2014 - 2025 (USD Billion) 6.6.2 South Africa 6.6.2.1 South Africa biomaterials market, 2014 - 2025 (USD Billion) Chapter 7 Competitive Landscape 7.1 Strategy Framework 7.2 Market Participation Categorization 7.3 Company Profiles 7.3.1 Medtronic plc 7.3.1.1 Company overview 7.3.1.2 Financial performance 7.3.1.3 Product benchmarking 7.3.1.4 Strategic initiatives
Follow Us:
7.3.2 Evonik Industries AG 7.3.2.1 Company overview 7.3.2.2 Financial performance 7.3.2.3 Product benchmarking 7.3.2.4 Strategic initiatives 7.3.3 Berkeley Advanced Biomaterials, Inc. 7.3.3.1 Company overview 7.3.3.2 Financial performance 7.3.3.3 Product benchmarking 7.3.3.4 Strategic initiatives 7.3.4 CAM Bioceramics BV. 7.3.4.1 Company overview 7.3.4.2 Financial performance 7.3.4.3 Product benchmarking 7.3.4.4 Strategic initiatives 7.3.5 Carpenter Technology Corporation 7.3.5.1 Company overview 7.3.5.2 Financial performance 7.3.5.3 Product benchmarking 7.3.5.4 Strategic initiatives 7.3.6 Invibio Ltd. 7.3.6.1 Company overview 7.3.6.2 Financial performance 7.3.6.3 Product benchmarking 7.3.6.4 Strategic initiatives 7.3.7 BASF SE 7.3.7.1 Company Overview 7.3.7.2 Financial performance 7.3.7.3 Product benchmarking 7.3.7.4 Strategic initiatives 7.3.8 Zimmer Biomet Holdings, Inc. 7.3.8.1 Company Overview
Follow Us:
7.3.8.2 Financial performance 7.3.8.3 Product benchmarking 7.3.8.4 Strategic initiatives 7.3.9 Covalon Technologies Ltd. 7.3.9.1 Company overview 7.3.9.2 Financial performance 7.3.9.3 Product benchmarking 7.3.9.4 Strategic initiatives 7.3.10 Collagen Matrix, Inc. 7.3.10.1 Company overview 7.3.10.2 Financial performance 7.3.10.3 Product benchmarking 7.3.10.4 Strategic initiatives
Follow Us:
About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us:
Follow Us: